None listed
Conditions
Brief summary
Aim? To examine whether a targeted and supervised exercise program can suppress tumour formation, growth and activity in advanced breast cancer patients with bone metastases in Humans and examine the feasibility, safety and efficacy of combining spinal isometric training with a modular multi-modal program M3EP program. Who is it for? You may be eligible to join this study if you are a female aged 18 years or more and have histologically confirmed breast cancer with one or more metastatic lesions in the thoracic or lumbar spine. Study details: Participants in this study will be randomly allocated (by chance) to one of two groups. Participants in one group receive a 12 week exercise intervention. The exercise intervention group will receive a 3-month, supervised and individually tailored modular multi-modal exercise program (M3EP) with spinal isometric training (SIT). M3EP component of the program will be comprised of resistance, aerobic and flexibility exercises undertaken 3 times per week in an exercise clinic setting, supervised by an accredited exercise physiologist. The SIT component of the program will comprise of exercises that isometrically load deep spinal muscles. These will be performed 5 times per week (3 in clinic and 2 at home). Participants in the other group will receive usual care for the duration of the trial. Following the trial, the control group will be offered the same exercise program if the intervention is deemed to be feasible and efficacious. All participants will complete assessments at baseline and after 12 weeks in order to evaluate tumour formation and growth, muscle-bone health, adiposity, physical fitness, functional capacity, and psychosocial health.
Interventions
This is a single-blinded (investigators blinded to group allocation), two-armed, randomised and controlled (exercise versus usual care) explorative phase 1 clinical trial which will examine the safety, feasibility and efficacy of combining spinal isometric training with a modulatory, multi-modal exercise program (M3EP-SIT) in women with advanced breast cancer and osteolytic spinal bone metastases. The exercise group (intervention arm) will receive an individually tailored and supervised three month (12 weeks) exercise program involving resistance, aerobic and flexibility exercises in addition to usual medical care. Participants assigned to the exercise arm will be required to participate in a modular, multi-modal exercise intervention with spinal isometric training (M3EP-SIT) for 12 weeks (3 months). The combined M3EP-SIT program requires participants to attend three supervised exercise sessions each week spanning 60 minutes in duration (including warm-up and cool-down). Participants will also be asked to perform the SIT program during two additional home-based exercise sessions spanning 15 minutes in duration. The M3EP component of the program will span 45 minutes, whereas the SIT component of the program will span 15 minutes (to make a 60 minute session during supervised sessions, and a 15 minute session during home-based, self-managed sessions). During the supervised exercise clinic sessions, patients will be provided with one-on-one supervision. The modular, multi-modal exercise (M3EP) component of the program will be comprised of resistance, aerobic and flexibility exercises undertaken 3 times per week in an exercise clinic setting, supervised by an accredited exercise physiologist (AEP, Exercise & Sport Science Australia). This M3EP component is designed to minimise loads on affected skeletal sites through-out the body. Exercise prescription will be modified based on the location and extent of bone metastases for all activities. Resistance exercise will be set using repetition maximums (RM). Participants will be asked to perform 10-12 RM for 3 sets per exercise to achieve moderate intensity and volume. Aerobic exercise will be set using age-predicted heart rate maximum (HRmax). Participants will engage in cardiovascular exercise using various modes including treadmill, cycling and rowing ergometers, performed at 60-85% HRmax for 20-30 minutes using heart rate monitors (Polar Electro Oy, Finland). Flexibility exercise will involve static stretching of all joints considered important for function, and for all muscles engaged during the session. All stretches will involve 2-4 sets per muscle group with a 30-60 second hold per set. The spinal isometric training (SIT) component of the program will comprise of exercises that isometrically load deep spinal muscles. These will be performed 5 times per week. Three sessions will be supervised by an accredited exercise physiologist synonymous with the M3EP component at an exercise clinic; with additional two sessions self-managed by the participant. This SIT component is designed to directly target and stimulate spinal lesion site(s) through muscular contraction, thus isometric exercises have been designed to activate the full spinal column due to the commonality of lesions in thoracic and lumbar regions; the feasibility of which has been demonstrated. The SIT program will require the participants to perform five exercises in whole and partial weight-supported prone and supine positions on the floor, whilst maintaining a neutral spine (isometrically) during gentle and dynamic accessory movements. Hip control and stationary spinal isometric exercises will first be used to ensure safe and correct technique during Week 1, prior to progressing to more challenging exercises which include less stability or dynamic accessory movements for Weeks 2 to 12. Adherence to supervised exercise sessions will be monitored and recorded by the exercise physiologists delivering the intervention. Patients will be provided with an exercise sheet for use during their twice weekly self-managed spinal isometric training sessions. Exercise sheets will be handed to the exercise physiologists at the patients next supervised session. Adherence to self-managed spinal isometric training will be subsequently be monitored and recorded by the exercise physiologist in consultation with the patient. This will be reported as a percentage of actual exercise completed versus prescribed exercise completed; as well as sessions missed as a ratio of sessions prescribed.
Sponsors
Study design
Eligibility
Inclusion criteria
* Female, aged greater than or equal to 18 years. * Histologically documented breast cancer. * Stable solitary or multiple metastatic osteolytic lesions in the thoracic or lumbar spine. * Greater than or equal to 3 months since last change of current primary therapies. * Greater than or equal to 3 months since commencement of new primary therapies. * Greater than or equal to 4 weeks since last major surgery and fully recovered * Eastern Cooperative Oncology Group (ECOG) Performance Status less than or equal to 1 * Medical clearance by treating physician to participate in exercise
Exclusion criteria
* Brain metastases or small cell neuroendocrine tumours’ * Currently receiving radiotherapy for thoracic or lumbar spinal metastases. Patients are permitted to receive radiotherapy for non-spinal bone metastases only during this intervention. * Currently receiving any other experimental treatments or non-approved therapies. * Regular participation in structured aerobic exercise greater than or equal to 2 days per week. * Regular participation in structured resistance exercise greater than or equal to 2 days per week. * Cardiovascular or neurological disorders that could inhibit exercise participation. * Diminished legal or perceived psychological capacity to given informed consent.